Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1883111000168116 | PKU Sphere20 Vanilla (glycomacropeptide formula with docosahexaenoic acid and low phenylalanine) powder for oral liquid, 30 x 35 g sachets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1883121000168111 | PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | Is a | trade product pack | true | Inferred relationship | Some | ||
| PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | Is a | glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 30 x 35 g sachets | true | Inferred relationship | Some | ||
| PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | has TPUU | PKU Sphere20 Vanilla powder for oral liquid, 35 g sachet | true | Inferred relationship | Some | 1 | |
| PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | has TP | PKU Sphere20 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | Is a | True | PKU Sphere20 Vanilla powder for oral liquid, 30 x 35 g sachets | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR